To include your compound in the COVID-19 Resource Center, submit it here.

Merck grants anti-infectives newco rights to antibiotic programs

Merck & Co. Inc. (NYSE:MRK) granted new anti-infectives company

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE